During the past decade, Vall d'Hebron Research Institute conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vall d'Hebron Research Institute" #1 sponsor was "Hospital Universitari Vall d'Hebron Research Institute" with 14 trials, followed by "Hendrik Streeck" with 1 trials sponsored, "King's College London" with 1 trials sponsored, "Modis Therapeutics, Inc." with 1 trials sponsored and "University of Calgary" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vall d'Hebron Research Institute" #1 collaborator was "Attention Deficit Disorder Information and Support Service" with 1 trials as a collaborator, "Barnet, Enfield and Haringey Mental Health NHS Trust" with 1 trials as a collaborator, "Concentris research management gmbh" with 1 trials as a collaborator, "Cumbria, Northumberland Tyne and Wear NHS Foundation Trust" with 1 trials as a collaborator and "Department of Health, Generalitat de Catalunya" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Vall d'Hebron Research Institute" are "Alzheimer´s Disease" (1 trials), "Attention Deficit Hyperactivity Disorder" (1 trials), "COVID-19" (1 trials), "Cardiovascular Diseases" (1 trials) and "Catheter-Related Infections" (1 trials). Many other conditions were trialed in "Vall d'Hebron Research Institute" in a lesser frequency.

Most popular intervention types in "Vall d'Hebron Research Institute" are "Other" (4 trials), "Behavioral" (3 trials), "Device" (3 trials), "Dietary Supplement" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "A warm ham and cheese sandwich and a 200 ml fruit juice" (1 trials), "Antiplatelet treatment" (1 trials), "Bimuno Galacto-oligosaccharide 1.37 g/d" (1 trials), "Biofeedback" (1 trials) and "Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vall d'Hebron Research Institute" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vall d'Hebron Research Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Vall d'Hebron Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vall d'Hebron Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".